Genotropin and Blood acid phosphatase abnormal - a phase IV clinical study of FDA data

Summary:

Blood acid phosphatase abnormal is reported only by a few people who take Genotropin.

The phase IV clinical study analyzes which people take Genotropin and have Blood acid phosphatase abnormal. It is created by eHealthMe based on reports of 25,241 people who have side effects while taking Genotropin from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 12, 2022

25,241 people reported to have side effects when taking Genotropin.
Among them, 3 people (0.01%) have Blood acid phosphatase abnormal.


What is Genotropin?

Genotropin has active ingredients of somatropin recombinant. It is often used in growth hormone deficiency. eHealthMe is studying from 18,657 Genotropin users for its effectiveness, alternative drugs and more.

What is Blood acid phosphatase abnormal?

Blood acid phosphatase abnormal is found to be associated with 2 drugs by eHealthMe.

Number of Genotropin and Blood acid phosphatase abnormal reports submitted per year:

Could Genotropin cause Blood acid phosphatase abnormal?

Gender of people who have Blood acid phosphatase abnormal when taking Genotropin *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Blood acid phosphatase abnormal when taking Genotropin *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common side effects people have besides Blood acid phosphatase abnormal *:

  1. Vitamin B12 Increased: 3 people, 100.00%
  2. Low Density Lipoprotein Increased (cholesterol increased in blood): 3 people, 100.00%
  3. High Density Lipoprotein Decreased: 3 people, 100.00%
  4. High Blood Cholesterol: 3 people, 100.00%
  5. Glycosylated Haemoglobin Increased: 3 people, 100.00%
  6. Eosinophil Count Increased: 3 people, 100.00%
  7. Blood Urea Nitrogen/creatinine Ratio Increased: 3 people, 100.00%
  8. Blood Thyroid Stimulating Hormone Decreased: 3 people, 100.00%
  9. Blood Glucose Increased: 3 people, 100.00%
  10. Rashes (redness): 2 people, 66.67%

Common conditions people have *:

  1. Empty Sella Syndrome (pituitary gland shrinks or becomes flattened): 3 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Genotropin and have Blood acid phosphatase abnormal?

Check whether Blood acid phosphatase abnormal is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Blood acid phosphatase abnormal and when was it recovered:

Expand to all the drugs that have ingredients of somatropin recombinant:

Alternative drugs to, pros and cons of Genotropin:

Common Genotropin side effects:

Browse all side effects of Genotropin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Blood acid phosphatase abnormal treatments and more:

COVID vaccines that are related to Blood acid phosphatase abnormal:

All the drugs that are associated with Blood acid phosphatase abnormal:

All the conditions that are associated with Blood acid phosphatase abnormal:

How the study uses the data?

The study uses data from the FDA. It is based on somatropin recombinant (the active ingredients of Genotropin) and Genotropin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: